Epidemiological analysis of morbidity and mortality from breast cancer including screening in Podkarpackie voivodeship in the years 1999–2010
Keywords:
breast cancer, morbidity, mortality, screeningAbstract
Introduction: In Pokarpackie voivodeship a continuous increase in morbidity and mortality from breast cancer in women is observed. In the years 1999-2010 a 56% increase in morbidity and 4,8% increase in mortality was reported. The aim of the study was to assess the trends in morbidity and mortality from breast cancer in women in Podkarpackie voivodeship in the years 1999-2010.
Materials and methods: 6 851 breast cancer cases and 2 627 deaths from breast cancer in women were analysed. Crude morbidity and mortality rates, standardized morbidity and mortality rates, structure rates and the participation of breast cancer cases detected in the screening programme were formulated.
Results: In 2010 an increase in breast cancer cases by 235 of newly diagnosed cases was observed in Podkarpackie voivodeship, in comparison with 1999. Crude and standardized rates of morbidity showed a rising tendency from 38,5/100 000 (standardized rate 28,6/100 000) in 1999 to 60,2/100 000 (standardized rate 39,4/100 000) in 2010. Mortality rates remained stable from 19,2/100 000 in 1999 to 20,2/100 000 in 2010. Standardized mortality rates showed a subtle decrease from 13,3/100 000 in 1999 to 11,5/100 000 in 2010. High differentiation in morbidity and mortality from breast cancer was observed in 2010 in the districts of Podkarpackie voivodeship. Morbidity rates ranged between 25,4-132,9/100 000, whereas mortality rates ranged between 0,0-44,4/100 000. The percentage share of breast cancer cases detected in the screening program in 2006-2010 increased by 19,5%.
Conclusions: In the years 1999-2010 the morbidity and mortality rates were lower in Podkarpackie voivodeship in comparison with the same rates for Poland in the same time. In the districts of Podkarpackie voivodeship in 2010 the highest value of the morbidity rate in Lesko District was 5-fold higher than the value found in Tarnobrzeg District, whereas the mortality rate in Strzyżów District was 44-fold higher in comparison with Bieszczady District. The percentage share of breast cancer cases detected in the screening programme increased in the years 2006-2010 from 3,7% to 23,2%.
Downloads
References
GLOBOCAN 2008; International Agency for Research on Cancer. http;//globocan.iarc.fr/
Baza danych Krajowego Rejestru Nowotworów.http://85.128.14.124/krn/
Wojciechowska U, Didkowska J, Zatoński W. Nowotwory złośliwe w Polsce - wskaźniki 5-letnich przeżyć według województw. Centrum OnkologiiInstytutim. M.Skłodowskiej-Curie. Warszawa 2010; 28-30.
Commission of the European: Report from the commission to the council, the European Parliament, the European economic and Social Committee and the Committee of the regions. Brussels 2008. http://ec.europa.eu/health/ph_determinants/genetics/documents/com_2008_882.en.pdf
DidkowskaJ, Wojciechowska U, Zatoński W. Prognozy zachorowalności i umieralności na nowotwory złośliwe w Polsce do 2025 roku. Centrum Onkologii Instytut im M.Skłodowskiej-Curie. Warszawa 2009; 45-49.
Wesołowska E. Badania przesiewowe w zakresie wczesnego wykrywania raka piersi.W: Podstawy onkologii klinicznej. red. Meder J. Centrum Medyczne Kształcenia Podyplomowego. Warszawa 2011; 17-21.
Didkowska J. Epidemiologia nowotworów złośliwych. W: Podstawy onkologii klinicznej. Red. Meder J. Centrum Medyczne Kształcenia Podyplomowego. Warszawa 2011; 5-16.
Baza danych Systemu Informatycznego Monitorowania Profilaktyki- program SIMP- dane nieopublikowane.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2013 Medical Journal of the Rzeszow University and the National Medicines Institute, Warsaw
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
